{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:23:22Z","timestamp":1792531402927,"version":"4.5.0"},"reference-count":39,"publisher":"American Chemical Society (ACS)","issue":"17","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/N034295\/1"],"award-info":[{"award-number":["EP\/N034295\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The protein kinase PfCLK3 plays a critical role in the regulation of malarial parasite RNA splicing and is essential for the survival of blood stage Plasmodium falciparum. We recently validated PfCLK3 as a drug target in malaria that offers prophylactic, transmission blocking, and curative potential. Herein, we describe the synthesis of our initial hit TCMDC-135051 (1) and efforts to establish a structure\u2013activity relationship with a 7-azaindole-based series. A total of 14 analogues were assessed in a time-resolved fluorescence energy transfer assay against the full-length recombinant protein kinase PfCLK3, and 11 analogues were further assessed in asexual 3D7 (chloroquine-sensitive) strains of P. falciparum parasites. SAR relating to rings A and B was established. These data together with analysis of activity against parasites collected from patients in the field suggest that TCMDC-135051 (1) is a promising lead compound for the development of new antimalarials with a novel mechanism of action targeting PfCLK3.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.0c00451","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T17:46:33Z","timestamp":1595958393000},"page":"9300-9315","source":"Crossref","is-referenced-by-count":41,"title":["Development of\nPotent\n                    <i>Pf<\/i>\n                    CLK3 Inhibitors\nBased on TCMDC-135051 as a New Class of Antimalarials"],"prefix":"10.1021","volume":"63","author":[{"given":"Amit","family":"Mahindra","sequence":"first","affiliation":[{"name":"University of Glasgow , , Joseph Black Building, University Avenue , ,","place":["Glasgow, U.K., G12 8QQ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Janha","sequence":"additional","affiliation":[{"name":"University of Glasgow , , Davidson Building , ,","place":["Glasgow, U.K., G12 8QQ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kopano","family":"Mapesa","sequence":"additional","affiliation":[{"name":"University of Glasgow , , Joseph Black Building, University Avenue , ,","place":["Glasgow, U.K., G12 8QQ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sanchez-Azqueta","sequence":"additional","affiliation":[{"name":"University of Glasgow , , Davidson Building , ,","place":["Glasgow, U.K., G12 8QQ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood M.","family":"Alam","sequence":"additional","affiliation":[{"name":"University of Glasgow , , ,","place":["Glasgow, U.K., G12 8TA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Amambua-Ngwa","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at LSHTM , Atlantic Boulevard, Fajara, P. O. Box 273, ,","place":["Banjul, The Gambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis C.","family":"Nwakanma","sequence":"additional","affiliation":[{"name":"MRC Unit The Gambia at LSHTM , Atlantic Boulevard, Fajara, P. O. Box 273, ,","place":["Banjul, The Gambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1807-3123","authenticated-orcid":true,"given":"Andrew B.","family":"Tobin","sequence":"additional","affiliation":[{"name":"University of Glasgow , , Davidson Building , ,","place":["Glasgow, U.K., G12 8QQ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1726-7353","authenticated-orcid":true,"given":"Andrew G.","family":"Jamieson","sequence":"additional","affiliation":[{"name":"University of Glasgow , , Joseph Black Building, University Avenue , ,","place":["Glasgow, U.K., G12 8QQ"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"2026090218244719400_cit1","unstructured":"Organization, WHO.\n          .  World Malaria Report, 2018."},{"key":"2026090218244719400_cit2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"K13-propeller mutations\nconfer artemisinin\nresistance in plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"2026090218244719400_cit3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant plasmodium\nfalciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"2026090218244719400_cit4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/s1473-3099(15)00487-9","article-title":"Dihydroartemisinin-piperaquine resistance\nin Plasmodium falciparum malaria in Cambodia: a multisite prospective\ncohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"2026090218244719400_cit5","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1128\/aac.00835-15","article-title":"Evidence of plasmodium falciparum malaria multidrug\nresistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine\nopen-label multicenter clinical assessment","volume":"59","author":"Leang","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026090218244719400_cit6","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.bbapap.2009.10.009","article-title":"Malaria: targeting\nparasite and host cell kinomes","volume":"1804","author":"Doerig","year":"2010","journal-title":"Biochim. Biophys.\nActa"},{"key":"2026090218244719400_cit7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrmicro3402","article-title":"Post-translational\nprotein modifications in malaria parasites","volume":"13","author":"Doerig","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"2026090218244719400_cit8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ncomms1558","article-title":"Global kinomic and phospho-proteomic\nanalyses of the human malaria parasite plasmodium falciparum","volume":"2","author":"Solyakov","year":"2011","journal-title":"Nat. Commun."},{"key":"2026090218244719400_cit9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/1471-2148-11-321","article-title":"Structural\nand evolutionary divergence\nof eukaryotic protein kinases in Apicomplexa","volume":"11","author":"Talevich","year":"2011","journal-title":"BMC Evol. Biol."},{"key":"2026090218244719400_cit10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00412-013-0407-z","article-title":"Regulation of splicing\nby SR proteins and SR protein-specific kinases","volume":"122","author":"Zhou","year":"2013","journal-title":"Chromosoma"},{"key":"2026090218244719400_cit11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105732","article-title":"Inhibition\nof the SR protein-phosphorylating\nCLK kinases of plasmodium falciparum impairs blood stage replication\nand malaria transmission","volume":"9","author":"Kern","year":"2014","journal-title":"PloS One"},{"key":"2026090218244719400_cit12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/jcb.23034","article-title":"Two nucleus-localized\nCDK-like kinases with crucial roles for malaria parasite erythrocytic\nreplication are involved in phosphorylation of splicing factor","volume":"112","author":"Agarwal","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"2026090218244719400_cit13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau1682","article-title":"Validation of the\nprotein kinase PfCLK3 as a multistage cross-species malarial drug\ntarget","volume":"365","author":"Alam","year":"2019","journal-title":"Science"},{"key":"2026090218244719400_cit14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1248\/cpb.c17-00380","article-title":"7-Azaindole: A versatile scaffold for developing kinase inhibitors","volume":"66","author":"Irie","year":"2018","journal-title":"Chem. Pharm. Bull."},{"key":"2026090218244719400_cit15","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1021\/jm800475y","article-title":"Knowledge\nbased prediction of ligand binding modes and rational inhibitor design\nfor kinase drug discovery","volume":"51","author":"Ghose","year":"2008","journal-title":"J. Med. Chem."},{"key":"2026090218244719400_cit16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1021\/acsmedchemlett.6b00518","article-title":"Design and\nsynthesis of potent and selective Pim kinase inhibitors by targeting\nunique structure of ATP-binding pocket","volume":"8","author":"Nakano","year":"2017","journal-title":"ACS\nMed. Chem. Lett."},{"key":"2026090218244719400_cit17","doi-asserted-by":"publisher","first-page":"19935","DOI":"10.3390\/molecules191219935","article-title":"The azaindole\nframework in the design of kinase inhibitors","volume":"19","author":"Me\u0301rour","year":"2014","journal-title":"Molecules"},{"key":"2026090218244719400_cit18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/376313a0","article-title":"Mechanism of CDK activation revealed\nby the structure of a cyclinA-CDK2 complex","volume":"376","author":"Jeffrey","year":"1995","journal-title":"Nature"},{"key":"2026090218244719400_cit19","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.1021\/acs.jmedchem.8b00329","article-title":"Plasmodial\nkinase inhibitors: license to cure?","volume":"61","author":"Cabrera","year":"2018","journal-title":"J. Med.\nChem."},{"key":"2026090218244719400_cit20","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1021\/jm901870q","article-title":"Discovery\nof GSK1070916, a potent and selective inhibitor of Aurora B\/C kinase","volume":"53","author":"Adams","year":"2010","journal-title":"J. Med. Chem."},{"key":"2026090218244719400_cit21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1021\/jm00272a008","article-title":"Synthesis\nof 1-p-chlorobenzyl-7-azaindole-3-.alpha.-piperidylmethanol as a potential\nantimalarial agent","volume":"15","author":"Verbiscar","year":"1972","journal-title":"J. Med. Chem."},{"key":"2026090218244719400_cit22","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1021\/jm401801t","article-title":"Differences\nin conformational dynamics between plasmodium falciparum and human\nHsp90 orthologues enable the structure-based discovery of pathogen-selective\ninhibitors","volume":"57","author":"Wang","year":"2014","journal-title":"J. Med. Chem."},{"key":"2026090218244719400_cit23","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1016\/j.bmcl.2017.08.069","article-title":"Discovery of N -substituted\n7-azaindoles as PIM1 kinase inhibitors - Part I","volume":"27","author":"Barberis","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026090218244719400_cit24","doi-asserted-by":"publisher","first-page":"7778","DOI":"10.1021\/jm900843g","article-title":"Inhibitors of Human Immunodeficiency\nVirus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles\nLeading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione\n(BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity\nin HIV-1-Infected Subjects","volume":"52","author":"Wang","year":"2009","journal-title":"J. Med. Chem."},{"key":"2026090218244719400_cit25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrd3847","article-title":"Vemurafenib: the first drug approved\nfor BRAF-mutant cancer","volume":"11","author":"Bollag","year":"2012","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026090218244719400_cit26","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1073\/pnas.1219457110","article-title":"Design and pharmacology of a highly\nspecific dual FMS and KIT kinase inhibitor","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026090218244719400_cit27","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1021\/jm301762v","article-title":"Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide\n(AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases","volume":"56","author":"Addie","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026090218244719400_cit28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1475-2875-12-187","article-title":"Designing\nthe next generation of\nmedicines for malaria control and eradication","volume":"12","author":"Burrows","year":"2013","journal-title":"Malar. J."},{"key":"2026090218244719400_cit29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12936-017-1809-9","article-title":"New developments\nin anti-malarial target candidate\nand product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"2026090218244719400_cit30","doi-asserted-by":"crossref","unstructured":"Godoi, P. H. C., Santiago, A. S., Ramos, P. Z., Fala, A. M., Salmazo, A. P. T., Counago, R. M., Righetto, G. L., Silva, P. N. B., Gileadi, O., Guimaraes, C. R. W., Massirer, K. B., Arruda, P., Elkins, J. M., Edwards, A. M.\n          Crystal\nstructure\nof the human PRPF4B in complex with Rebastinib; Structural Genomics Consortium (SGC)2018.","DOI":"10.2210\/pdb6cnh\/pdb"},{"key":"2026090218244719400_cit31","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1016\/j.bmcl.2012.06.065","article-title":"4-Phenyl-7-azaindoles\nas potent,\nselective and bioavailable IKK2 inhibitors demonstrating good in vivo\nefficacy","volume":"22","author":"Liddle","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026090218244719400_cit32","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/infdis\/jit618","article-title":"Changes in malaria\nparasite drug resistance in an endemic population over a 25-year period\nwith resulting genomic evidence of selection","volume":"209","author":"Nwakanma","year":"2013","journal-title":"J. Infect. Dis."},{"key":"2026090218244719400_cit33","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00759-17","article-title":"Sustained\nex vivo susceptibility\nof plasmodium falciparum to artemisinin derivatives but increasing\ntolerance to artemisinin combination therapy partner quinolines in\nThe Gambia","volume":"61","author":"Amambua-Ngwa","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026090218244719400_cit34","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.1039\/c2ob25880c","article-title":"Asymmetric synthesis of (+)-vertine and (+)-lythrine","volume":"10","author":"Chausset-Boissarie","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"2026090218244719400_cit35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0010029","article-title":"Molecular\nidentification of a malaria\nmerozoite surface sheddase","volume":"1","author":"Harris","year":"2005","journal-title":"PLoS Pathog."},{"key":"2026090218244719400_cit36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4236\/ojepi.2015.51010","article-title":"In Vitro culture\nof\nplasmodium falciparum obtention of synchronous asexual erythrocytic\nstages","volume":"05","author":"Roncale\u0301s","year":"2015","journal-title":"Open J. Epidemiol."},{"key":"2026090218244719400_cit37","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction\nof human clearance of twenty-nine drugs from hepatic microsomal intrinsic\nclearance data: an examination of in vitro half-life approach and\nnonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab.\nDispos."},{"key":"2026090218244719400_cit38","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1021\/ac961242d","article-title":"Chromatographic hydrophobicity index\nby fast-gradient RP-HPLC: a high-throughput alternative to log P\/log\nD","volume":"69","author":"Valko\u0301","year":"1997","journal-title":"Anal. Chem."},{"key":"2026090218244719400_cit39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.0c00451","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/63\/17\/9300\/67036222\/acs.jmedchem.0c00451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/63\/17\/9300\/67036222\/acs.jmedchem.0c00451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:24:55Z","timestamp":1788387895000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/63\/17\/9300\/1340988\/Development-of-Potent-PfCLK3-Inhibitors-Based-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":39,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2020,7,28]]},"published-print":{"date-parts":[[2020,9,10]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00451","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv.9817202.v1","asserted-by":"object"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]}}}